Navegar por autor "Fernández Calvo, Ovidio"

Analysis of the expression of Wnt signaling ligands in metastatic renal cell carcinomas tissue samples

2012- Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; León Mateos, Luis Ángel; [et al.]

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

2013- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; [et al.]

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

2013- Pena Álvarez, Carolina; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Varela Ferreiro, Silvia; Campos Balea, Begoña [et al.]

DESCRIPTION OF A SUBPOPULATION OF RENAL PATIENTS WITH LONG-TERM PROGRESSION FREE SURVIVAL (PFS) WITH SUNITINIB: A SOG_GU EXPERIENCE

2012- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio

Efficacy and safety of Temsirolimus in patients with metastatic renal cell carcinoma: Final results from the Spanish experience

2015- Fernández Calvo, Ovidio

Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor

2015- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Lazaro Quintela, Martín; [et al.]

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study

2012- Afonso Afonso, Francisco Javier; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Fernández Montes, Ana; [et al.]

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)

2011- Fernández Calvo, Ovidio; García Mata, Jesús; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]

Expression of Notch family members in stage IV renal cell carcinoma tumors: Notch1 as medium-risk prognosis factor

2012- Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; León Mateos, Luis Ángel; [et al.]

Expression of notch1 to -4 and their ligands in renal cell carcinoma: A tissue microarray study

2011- Antón Aparicio, Luis Miguel; Aparicio Gallego, Guadalupe; Medina Villaamil, Vanessa; Santamarina Cainzos, Isabel; Fernández Calvo, Ovidio; [et al.]

GAPDH, YWHAZ, and RRN18S as control reference genes for gene expression studies on renal cell carcinoma (RCC) formaldehyde-fixed paraffin-embedded (FFPE) tissue samples

2011- Afonso Afonso, Francisco Javier; Valladares Ayerbes, Manuel; Antón Aparicio, Luis Miguel; Medina Villaamil, Vanessa; Fernández Calvo, Ovidio; [et al.]

GGCP041/09: A GALICIAN STUDY OF SECOND-LINE ERLOTINIB IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC

2012- Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]

GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC)

2012- Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience

2012- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; [et al.]

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel

2014- Antón Aparicio, Luis Miguel; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; [et al.]

Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS assessed both in tumor and blood sample, as a marker of response to enzalutamide in patients with metastatic castration resistant prostate cancer (CRPC) pre-chemotherapy

2015- Fernández Calvo, Ovidio; Vázquez Estévez, Sergio

Phase II study of weekly cabazitaxel for

2013- Anido Herranz, Urbano; Fernández Calvo, Ovidio

Radium-223 dichloride: A new paradigm in the treatment of prostate cancer

2015- Afonso Afonso, Francisco Javier; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Lazaro Quintela, Martín; Vázquez Estévez, Sergio [et al.]

Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract (TCCU) after failure to one cisplatin-based systemic therapy in clinical practice

2014- Fernández Calvo, Ovidio

Sunitinib: The first to arrive at first-line metastatic renal cell carcinoma

2012- Antón Aparicio, Luis Miguel; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; Lazaro Quintela, Martín; Vázquez Estévez, Sergio [et al.]

Repositorio digital RUNA

Navegar por autor "Fernández Calvo, Ovidio"

Analysis of the expression of Wnt signaling ligands in metastatic renal cell carcinomas tissue samples ﻿

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor ﻿

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group ﻿

DESCRIPTION OF A SUBPOPULATION OF RENAL PATIENTS WITH LONG-TERM PROGRESSION FREE SURVIVAL (PFS) WITH SUNITINIB: A SOG_GU EXPERIENCE ﻿

Efficacy and safety of Temsirolimus in patients with metastatic renal cell carcinoma: Final results from the Spanish experience ﻿

Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor ﻿

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study ﻿

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09) ﻿

Expression of Notch family members in stage IV renal cell carcinoma tumors: Notch1 as medium-risk prognosis factor ﻿

Expression of notch1 to -4 and their ligands in renal cell carcinoma: A tissue microarray study ﻿

GAPDH, YWHAZ, and RRN18S as control reference genes for gene expression studies on renal cell carcinoma (RCC) formaldehyde-fixed paraffin-embedded (FFPE) tissue samples ﻿

GGCP041/09: A GALICIAN STUDY OF SECOND-LINE ERLOTINIB IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC ﻿

GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC) ﻿

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience ﻿

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel ﻿

Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS assessed both in tumor and blood sample, as a marker of response to enzalutamide in patients with metastatic castration resistant prostate cancer (CRPC) pre-chemotherapy ﻿

Phase II study of weekly cabazitaxel for ﻿

Radium-223 dichloride: A new paradigm in the treatment of prostate cancer ﻿

Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract (TCCU) after failure to one cisplatin-based systemic therapy in clinical practice ﻿

Sunitinib: The first to arrive at first-line metastatic renal cell carcinoma ﻿

Analysis of the expression of Wnt signaling ligands in metastatic renal cell carcinomas tissue samples

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

DESCRIPTION OF A SUBPOPULATION OF RENAL PATIENTS WITH LONG-TERM PROGRESSION FREE SURVIVAL (PFS) WITH SUNITINIB: A SOG_GU EXPERIENCE

Efficacy and safety of Temsirolimus in patients with metastatic renal cell carcinoma: Final results from the Spanish experience

Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)

Expression of Notch family members in stage IV renal cell carcinoma tumors: Notch1 as medium-risk prognosis factor

Expression of notch1 to -4 and their ligands in renal cell carcinoma: A tissue microarray study

GAPDH, YWHAZ, and RRN18S as control reference genes for gene expression studies on renal cell carcinoma (RCC) formaldehyde-fixed paraffin-embedded (FFPE) tissue samples

GGCP041/09: A GALICIAN STUDY OF SECOND-LINE ERLOTINIB IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC

GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC)

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel

Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS assessed both in tumor and blood sample, as a marker of response to enzalutamide in patients with metastatic castration resistant prostate cancer (CRPC) pre-chemotherapy

Phase II study of weekly cabazitaxel for

Radium-223 dichloride: A new paradigm in the treatment of prostate cancer

Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract (TCCU) after failure to one cisplatin-based systemic therapy in clinical practice

Sunitinib: The first to arrive at first-line metastatic renal cell carcinoma